Hospitalisations related to lower respiratory tract infections in Northern Queensland

Pak, Anton; Adegboye, Oyelola A.; Eisen, Damon P.; McBryde, Emma S.

doi:10.1111/1753-6405.13104

Cited by 5 publications

(3 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The problem of poor health care associated with higher morbidity among the Indigenous populations is not limited to the inhabitants of the Sierra Nevada de Santa Marta. This can also be observed in other countries with regard to the number of communicable diseases [20][21][22][23][24], non-communicable diseases [25,26], or oral health [27]. Unfortunately, datasets on many indigenous people in other countries are incomplete or missing com-pletely.…”

Section: Discussionmentioning

confidence: 92%

Prevalence of Common Diseases in Indigenous People in Colombia

Bauer

Mendoza²,

Kreienbrock

et al. 2022

TropicalMed

View full text Add to dashboard Cite

The Indigenous tribe called the Wiwa lives retracted in the Sierra Nevada de Santa Marta, Colombia. Little is known about their health status and whether the health care system in place covers their needs. In 2017 and 2018, a permanent physician was in charge for the Wiwa. Diseases and complaints were registered, ranked, and classified with the ICD-10 coding. Datasets from the Indigenous health care provider Dusakawi, collected from local health points and health brigades travelling sporadically into the fields for short visits, were compared. Furthermore, a list of provided medication was evaluated regarding the recorded needs. The most common complaints found were respiratory, infectious and parasitic, and digestive diseases. The top ten diagnoses collected in the health points and in the health brigade datasets were similar, although with a different ranking. The available medication showed a basic coverage only, with a critical lack of treatment for many severe, chronic, and life-threatening diseases. Most of the detected diseases in the Indigenous population are avoidable by an improvement in health care access, an expansion of the provided medication, and an increase in knowledge, hygiene, and life standards.

show abstract

Section: Discussionmentioning

confidence: 92%

Prevalence of Common Diseases in Indigenous People in Colombia

Bauer

Mendoza²,

Kreienbrock

et al. 2022

TropicalMed

View full text Add to dashboard Cite

show abstract

“…As has been noted previously, given the younger age of the Aboriginal and Torres Strait Islander cohort, the apparently equivalent APACHE scores at presentation likely reflect more significant physiological perturbation and organ failure at presentation when compared with the non-Indigenous comparison population. 11 The observed high rates of pulmonary source of sepsis have been described in other populations of Aboriginal and Torres Strait Islander people, 4,20 as have the low rates of intra-abdominal infection. 9 The outcomes for this population of critically ill Aboriginal and Torres Strait Islander patients differ to those reported previously.…”

Section: Discussionmentioning

confidence: 89%

Outcomes following severe septic shock in a cohort of Aboriginal and Torres Strait Islander people: a nested cohort study from the ADRENAL trial

Donaldson¹,

Hammond²,

Agarwal³

et al. 2022

Critical Care and Resuscitation

View full text Add to dashboard Cite

OBJECTIVE: To describe the pattern of acute illness and 6-month mortality and health-related quality-of-life outcomes for a cohort of Aboriginal and Torres Strait Islander patients presenting with septic shock. DESIGN: Nested cohort study of Aboriginal and Torres Strait Islander participants recruited to a large randomised controlled trial of corticosteroid treatment in patients with septic shock. SETTING: Royal Darwin Hospital, Northern Territory. PARTICIPANTS: All Aboriginal and Torres Strait Islander patients recruited to the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock (ADRENAL) trial at Royal Darwin Hospital were compared with a non-Indigenous cohort drawn from the same site, and a cohort matched for age, sex and severity of disease. MAIN OUTCOME MEASURES: Mortality at 90 days and 6 months, time to shock resolution, mechanical ventilation requirement, renal replacement therapy requirement, and five-domain, five-level EuroQol questionnaire (EQ-5D-5L) score at 6 months. RESULTS: Aboriginal and Torres Strait Islander patients had significantly reduced risk of death at 90 days when compared with non-Indigenous patients recruited to ADRENAL at Royal Darwin Hospital (12/60 v 23/62; adjusted odds ratio, 0.40 [95% CI, 0.17 to 0.94]) which was robust to additional adjustment for baseline covariates (odds ratio, 0.35 [95% CI, 0.14 to 0.90]). When compared with the matched population drawn from the broader ADRENAL cohort, there was no significant difference in 90-day mortality (12/60 v 16/61; adjusted odds ratio, 1.43 [95% CI, 0.60 to 3.39]; P = 0.42). Only nine Aboriginal and Torres Strait Islander patients provided 6-month health-related quality-of-life data. CONCLUSIONS: Aboriginal and Torres Strait Islander patients had reduced risk of death at 90 days when compared with non-Indigenous patients recruited to the ADRENAL trial at Royal Darwin Hospital, which was robust to adjustment for covariates, but similar outcomes when compared with a cohort matched for age, sex and severity of disease.

show abstract

“…Lower respiratory tract infections (LRTIs) pose a significant global public health challenge, standing as a leading cause of mortality among individuals; spanning from children to adults worldwide 1 . In developing countries, the prevalence of LRTIs and pneumonia is markedly higher in developing countries, ranging between 20% and 30%, as compared to the lower rates of 3% to 4% observed in developed nations 2 .…”

Section: Introductionmentioning

confidence: 99%

Microbial Characteristics of Lower Respiratory Tract Infections in Patients Referred from Primary Care Hospitals

Nguyen-Van,

Pham-Hung,

Tran-Van,

et al. 2023

J Health Sci Med Res

View full text Add to dashboard Cite

Objective: This study investigated the microbiological characteristics of severe lower respiratory tract infection patients not respond to initial treatment, and were transferred to a tertiary-level hospital.Material and Methods: This was a multicenter, prospective study conducted across four hospitals: Cho Ray, Pham Ngoc Thach, Gia Dinh People’s Hospital, and Can Tho Central General Hospital. Sputum specimens were collected shortly after admission and subjected to culture and real-time PCR testing.Results: Out of the 252 patients, 170 (67.4%) met the criteria for analysis and identification of pathogenic microorganisms. The most frequently isolated pathogens were Streptococcus pneumoniae (S. pneumonia) and Haemophilus influenzae (H. influenzae), comprising of 27.0% and 13.1%, respectively. Antibiotic susceptibility testing was conducted on 55 patients (32.3%). Among these cases, there were 16 instances of S. pneumoniae, 10 cases of Staphylococcus aureus (S. aureus), 10 cases of Pseudomonas aeruginosa (P. aeruginosa), 14 cases of gram-negative enteric bacteria, 2 cases of H. influenzae, 1 case of Moraxella catarrhalis (M. catarrhalis), 1 case of Enterococcus faecium, and 1 case of M. pneumoniae. The antibiogram results revealed significant findings; including a 70% prevalence of extended-spectrum beta-lactamase and 90% occurrence of Methicillin-Resistant Staphylococcus aureus. The data also indicated high resistance rates; such as 90% resistance to erythromycin, 40-80% to ciprofloxacin, 30-80% to ceftazidime, and 30-40% to imipenem.Conclusion: Pathogens associated with LRTIs referred from primary care hospitals encompass S. pneumonia, H. influenza, and S. aureus. At our facility, piperacillin, imipenem, amikacin, vancomycin, and linezolid emerged as the most effective antibiotics for addressing these LRTIs.

show abstract

Hospitalisations related to lower respiratory tract infections in Northern Queensland

Cited by 5 publications

References 30 publications

Prevalence of Common Diseases in Indigenous People in Colombia

Prevalence of Common Diseases in Indigenous People in Colombia

Outcomes following severe septic shock in a cohort of Aboriginal and Torres Strait Islander people: a nested cohort study from the ADRENAL trial

Microbial Characteristics of Lower Respiratory Tract Infections in Patients Referred from Primary Care Hospitals

Contact Info

Product

Resources

About